ArcBest ARCB Industry Outlook ArcBest Posts 128 EPS Miss Amid Cost Pressures CTXR Citius Pharma shares drop 17 percent after widerthanexpected Q4 2025 loss rattles investor confidence US Aviation Sector SingleCarrier Bailout Negotiations and Industry Implications How MiNK Therapeutics INKT earnings power stacks up historically Q4 2025 Profit Surprises Materials Select Sector SPDR Fund XLB